Regeneron Pharmaceuticals Business Finance Contracts & Agreements
47 Contracts & Agreements
- Credit Agreements (7 contracts)
- Guaranty Agreements (3)
- Indenture Agreements (3)
- Modification Agreements (9)
- Note Agreements (2)
- Participation Agreements (4)
- Registration Rights Agreements (1)
- Repurchase Agreements (1)
- Stock Agreements (10)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (2)
- Third Amended and Restated Participation Agreement, dated as of March 27, 2023, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,... (Filed With SEC on March 29, 2023)
- Third Amended and Restated Guaranty, dated as of March 27, 2023, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,... (Filed With SEC on March 29, 2023)
- Credit Agreement, dated as of December 19, 2022, by and among Regeneron Pharmaceuticals, Inc., as a borrower and guarantor; certain direct subsidiaries of Regeneron... (Filed With SEC on December 20, 2022)
- Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on November 3, 2022)
- Modification No. 0 (Filed With SEC on August 3, 2022)
- Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on May 4, 2022)
- Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International (Filed With SEC on May 4, 2022)
- Second Amended and Restated Participation Agreement, dated as of March 2, 2022, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,... (Filed With SEC on March 8, 2022)
- Second Amended and Restated Guaranty, dated as of March 2, 2022, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,... (Filed With SEC on March 8, 2022)
- Amendment No. 1 to Credit Agreement, dated as of November 11, 2021, by and among the Registrant, as a borrower and guarantor; certain direct subsidiaries of the Registrant, as... (Filed With SEC on February 7, 2022)
- First Amendment to Amended and Restated Participation Agreement, dated as of October 6, 2021, by and among Old Saw Mill Holdings LLC, as lessee; the Registrant, as parent... (Filed With SEC on February 7, 2022)
- Modification No. 01 to Project Agreement, dated as of October 13, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)
- Modification No. 02 to Project Agreement, dated as of November 17, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)
- Underwriting Agreement, dated August 7, 2020, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc., and J.P. Morgan Securities LLC, as representatives of the... (Filed With SEC on August 12, 2020)
- Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association (Filed With SEC on August 12, 2020)
- First Supplemental Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association (Filed With SEC on August 12, 2020)
- Amendment No. 1 to Credit Agreement, dated as of June 11, 2020, by and between the Registrant, as borrower, and Goldman Sachs Bank USA, as administrative agent (Filed With SEC on August 5, 2020)
- Underwriting Agreement, dated as of May 26, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Aventisub LLC, and BofA Securities, Inc. and Goldman Sachs & Co. LLC, as... (Filed With SEC on May 29, 2020)
- Stock Repurchase Agreement, dated as of May 25, 2020, by and between Regeneron Pharmaceuticals, Inc. and Sanofi (Filed With SEC on May 29, 2020)
- Credit Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., as borrower; Goldman Sachs Bank USA, as administrative agent, sole bookrunner, sole lead... (Filed With SEC on May 29, 2020)
- Stock Purchase Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
- Amended and Restated Guaranty, dated as of May 2, 2019, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC, as... (Filed With SEC on May 3, 2019)
- Amended and Restated Participation Agreement, dated as of May 2, 2019, by and among Old Saw Mill Holdings LLC, as lessee; Bank of America, N.A., as administrative agent; BA... (Filed With SEC on May 3, 2019)
- Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to the Registrant's executive officers under the Amended... (Filed With SEC on February 8, 2018)
- Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to P. Roy Vagelos, M.D. under the Amended and Restated... (Filed With SEC on February 8, 2018)
- Date:February 22, 2016To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River... (Filed With SEC on May 5, 2016)
- Regeneron Pharmaceuticals, Inc.Notice of Grant of Stock OptionsID:[]and Option Agreement777 Old Saw Mill River RoadTarrytown, New York 10591[OPTIONEE NAME]OptionNumber:[][OPTIONEE... (Filed With SEC on February 11, 2016)
- Date:November 15, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River... (Filed With SEC on February 11, 2016)
- Date:August 5, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River... (Filed With SEC on November 4, 2015)
- Amendment, dated as of May 14, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,... (Filed With SEC on August 5, 2014)
- REGENERON PHARMACEUTICALS, INC. Incentive Stock Option OPTION AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN (Filed With SEC on June 18, 2014)
- REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 PURCHASE AGREEMENT (Filed With SEC on October 24, 2011)
- REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 INDENTURE Dated as of October 21, 2011 WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee (Filed With SEC on October 24, 2011)
- REGENERON PHARMACEUTICALS, INC. 1.875% Convertible Senior Notes due 2016 (Filed With SEC on October 24, 2011)
- MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN CREDIT SUISSE INTERNATIONAL AND REGENERON PHARMACEUTICALS, INC. (Filed With SEC on October 24, 2011)
- 5,500,000 SHARES REGENERON PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 13, 2010)
- EX-4.1: FORM OF CERTIFICATE OF SHARES OF COMMON STOCK (Filed With SEC on August 1, 2008)
